CWF19L1
CWF19-like protein 1
Also known as: C19L1_HUMAN, FLJ10998, hDrn1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q69YN2
- Gene
- CWF19L1
- Ensembl
- ENSG00000095485
- Chromosome
- 10
- Canonical length
- 538 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
538 residues, UniProt reviewed canonical sequence.
>Q69YN2|CWF19L1
1 MAQKPLRLLA CGDVEGKFDI LFNRVQAIQK KSGNFDLLLC VGNFFGSTQD AEWEEYKTGI
61 KKAPIQTYVL GANNQETVKY FQDADGCELA ENITYLGRKG IFTGSSGLQI VYLSGTESLN
121 EPVPGYSFSP KDVSSLRMML CTTSQFKGVD ILLTSPWPKC VGNFGNSSGE VDTKKCGSAL
181 VSSLATGLKP RYHFAALEKT YYERLPYRNH IILQENAQHA TRFIALANVG NPEKKKYLYA
241 FSIVPMKLMD AAELVKQPPD VTENPYRKSG QEASIGKQIL APVEESACQF FFDLNEKQGR
301 KRSSTGRDSK SSPHPKQPRK PPQPPGPCWF CLASPEVEKH LVVNIGTHCY LALAKGGLSD
361 DHVLILPIGH YQSVVELSAE VVEEVEKYKA TLRRFFKSRG KWCVVFERNY KSHHLQLQVI
421 PVPISCSTTD DIKDAFITQA QEQQIELLEI PEHSDIKQIA QPGAAYFYVE LDTGEKLFHR
481 IKKNFPLQFG REVLASEAIL NVPDKSDWRQ CQISKEDEET LARRFRKDFE PYDFTLDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CWF19L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 18 nTPM
- tonsil: 16 nTPM
- lymph node: 15 nTPM
- testis: 15 nTPM
- thymus: 14 nTPM
- spleen: 12 nTPM
Single-cell type
- neutrophil progenitors: 73 nCPM
- neutrophils: 72 nCPM
- myonuclei: 61 nCPM
- monocyte progenitors: 55 nCPM
- b-cells: 50 nCPM
- rod photoreceptor cells: 44 nCPM
Immune cell
- eosinophil: 23 nTPM
- NK-cell: 18 nTPM
- T-reg: 18 nTPM
- classical monocyte: 17 nTPM
- MAIT T-cell: 16 nTPM
- intermediate monocyte: 16 nTPM
Brain region
- white matter: 15 nTPM
- cerebellum: 13 nTPM
- hypothalamus: 11 nTPM
- spinal cord: 11 nTPM
- cerebral cortex: 11 nTPM
- pons: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CWF19L1.
Disease | AllUniProt
Conditions CWF19L1 is implicated in, by any mechanism.
- Spinocerebellar ataxia, autosomal recessive, 17 (SCAR17) MIM:616127
Disease | GeneticClinVar
31 pathogenic / likely-pathogenic of 162 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive spinocerebellar ataxia 17
- Intellectual disability
- CWF19L1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- via spliceosome
- mRNA splicing
Molecular functions
- RNA lariat debranching enzyme activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CWF19L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CWF19L1 as an antibody target. Whether an autoantibody or antibody against CWF19L1 could matter depends on whether native CWF19L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CWF19L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CWF19L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...